UK HomeAcademic Programs Athletics Chandler Medical Center Research and Graduate StudiesSite IndexSearch UK Medical Center
  

Charles Mactutus
Ph.D.

            In Utero Cocaine Exposure: 

Our recent data provide convergence across a variety of disciplines that indicate prenatal cocaine is a neurobehavioral teratogen when administered by a clinically relevant route (IV) and at physiologically relevant peak arterial plasma levels, and moreover, that the central noradrenergic system is a very important target for these effects. Our current program maintains the hypothesis: Maternal cocaine abuse during a restricted portion of pregnancy causes long-term and selective alterations in 1) "attentionally sensitive" neurobehavioral paradigms and 2) the structure and function of the central noradrenergic system; both of which are attributable to early noradrenergic cell dysfunction/loss in the locus coeruleus.  The specific aims of the program are: First, to establish the critical exposure period for the neurobehavioral alterations which occur in the offspring consequent to intravenous maternal cocaine exposure during pregnancy. Using ontogenetic and longitudinal analyses, the proposed studies will replicate and extend our prior studies by specifically identifying the critical exposure period(s). We will use noradrenergically mediated and/or attentionally sensitive tasks to provide an assessment of both ascending and descending noradrenergic projections of the locus coeruleus.  Multiple dependent measures within each task will provide the dissociation of specific neural and cognitive deficits from sensory or motor impair­ments. Second, To establish the critical exposure period for the structural and functional alterations in the central noradrenergic system alterations which occur in the offspring consequent to IV maternal cocaine exposure during pregnancy. Quantitative neuroanatomical measurements (unbiased cell-counting/optical disector technique), immunocytochemistry, synthetic enzyme activity, and in situ hybridization will be utilized to fundamentally establish whether the observed alterations in the central noradrenergic system, presumably reflecting compensatory processes in the developing CNS, occur in response to noradrenergic cell loss or, alternatively, to a less permanent cellular dysfunction.  The goal of the proposed program is to determine whether the early cell dysfunction/loss in the locus coeruleus may provide a potential underlying basis for the long-term and selective alterations in attentionally sensitive neurobehavioral paradigms consequent to prenatal cocaine exposure.

 

Return to Dr. Mactutus' main page


122 Tobacco and Health Research Bldg., Lexington, KY 40536-0082 - Phone (859) 257-4788 - Fax (859) 323-1077


______________________________________________________________________

Pharmaceutical Sciences | College of Pharmacy

 Comments to J. Carol Guinnup, Last Modified: February 02, 2001
 Copyright © 1999, University of Kentucky Chandler Medical Center